Pergi ke luar talian dengan aplikasi Player FM !
Unraveling Neuroinflammation: Dr. Kendra McLaughlin on Microglia, Biomarkers, and Innovative Therapies for Brain Health
Manage episode 448741445 series 3493690
Dr. Kendra McLaughlin, an assistant professor at UNLV, discusses her research on neuroinflammation and microglia, immune cells in the brain. She explains how microglia, which can protect neurons, can also become overactive and harmful under chronic stress or disease, contributing to neurodegenerative conditions like Alzheimer's and Parkinson's. Dr. McLaughlin highlights the importance of early detection through biomarkers and innovative therapies, such as TSPO modulators and cannabinoid-based treatments targeting CB2 receptors. She emphasizes the need for interdisciplinary approaches, including engineering models, to better understand and manage neuroinflammation, aiming for personalized medicine and early intervention to mitigate brain damage.
24 episod
Manage episode 448741445 series 3493690
Dr. Kendra McLaughlin, an assistant professor at UNLV, discusses her research on neuroinflammation and microglia, immune cells in the brain. She explains how microglia, which can protect neurons, can also become overactive and harmful under chronic stress or disease, contributing to neurodegenerative conditions like Alzheimer's and Parkinson's. Dr. McLaughlin highlights the importance of early detection through biomarkers and innovative therapies, such as TSPO modulators and cannabinoid-based treatments targeting CB2 receptors. She emphasizes the need for interdisciplinary approaches, including engineering models, to better understand and manage neuroinflammation, aiming for personalized medicine and early intervention to mitigate brain damage.
24 episod
Semua episod
×Selamat datang ke Player FM
Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.